Details for New Drug Application (NDA): 086766
✉ Email this page to a colleague
NDA 086766 describes NITROFURAZONE, which is a drug marketed by Ambix, Lannett, Perrigo New York, Taro, and Wendt, and is included in seven NDAs. Additional details are available on the NITROFURAZONE profile page.
The generic ingredient in NITROFURAZONE is nitrofurazone. There are four drug master file entries for this compound. Additional details are available on the nitrofurazone profile page.
The generic ingredient in NITROFURAZONE is nitrofurazone. There are four drug master file entries for this compound. Additional details are available on the nitrofurazone profile page.
Summary for 086766
| Tradename: | NITROFURAZONE |
| Applicant: | Wendt |
| Ingredient: | nitrofurazone |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 086766
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;TOPICAL | Strength | 0.2% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
